课题基金 / 基金详情

Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)

Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)
评估远程医疗对终末期肾病 (ESKD) 患者的作用
批准号:
10447360
负责人:
Joel Thomas Adler
金额:
$14.42万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
7. PROJECT SUMMARY The 60 million rural dwellers across the United States are older, more likely to live in poverty, and more likely to be either underinsured or uninsured compared to their urban counterparts. Moreover, the 240,000 rural patients with end stage kidney disease (ESKD) have less access to nephrology care, are less likely to finish pre-kidney transplant evaluation, and are less likely to undergo kidney transplantation. Telehealth is uniquely positioned to overcome geographic barriers of rural America by capitalizing on electronic information and telecommunication technologies. Yet telehealth is underutilized among rural patients in general, and little is known about how geography, resources, and distance to healthcare facilities contribute to access to care, outcomes, and quality of life for rural patients with ESKD. A comprehensive study of utilization, cost-effectiveness, and patient and provider preferences would be an important step in expanding telehealth policies specifically aimed to care for the rural ESKD population. We propose the following specific aims: (1) to assess the costs, utilization, and outcomes associated with telehealth for rural patients with ESKD; (2) to compare telehealth provision of ESKD care to standard in-office care in the rural ESKD population using model-based cost-effectiveness analysis; and (3) to understand facilitators and barriers of using telehealth from the perspective of patients and providers. A detailed training plan for Joel T. Adler, MD, MPH, is outlined in this proposal. In brief, it includes in-depth coursework to extend and expand Dr. Adler’s research skills, a practicum experience with the RURAL (Risk Underlying Rural Areas Longitudinal) Cohort study in the southern rural United States, and a mentorship plan jointly prepared by the principal investigator and a team with expertise in kidney disease, health services research, qualitative research, cost-effectiveness analysis, and the mentorship of junior clinician-scientists. This will help the candidate meet the following career goals: (1) gain state of the art expertise in large claims database, geographic information systems, cost-effectiveness, and qualitative research, (2) apply for and obtain R01 grant funding, and (3) transition to academic independence. When completed, Dr. Adler will have learned the perspectives of rural patients with EKSD and providers on telehealth that will be methodically crucial in designing pilot studies that inform R01 proposals to increase accessibility and utilization of telehealth on a population-health level for rural patents with ESKD. These efforts will culminate in a comprehensive understanding of the role of telehealth in caring for rural patients with ESKD by economic assessment of its utilization, a cost-effectiveness analysis for implementation on a wider scale, and learning how these align with patient and provider preferences to inform future policy regarding telehealth utilization and reimbursement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵培泉
  • 依托单位: